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ABSTRACT
We have found that DnaA dependent replication of RI
still occurred when 5 of the 9 bases in the dnaA box
present in oriR were changed by site directed
mutagenesis although the replication efficiency
decreased to 20% and 70% of the wild-type origin in
vitro and In vivo respectively. Additional mutation of
a second dnaA box, 28 bp upstream oriR, that differs
in only one base from the consensus sequence, did not
affect the level of replication whereas polyclonal
antibodies against DnaA totally abolished in vitro
replication in the absence of the dnaA box. Wild-type
RepA as well as a RepA mutant, RepA2623, that binds
to oriR but that is inactive in promoting in vitro
replication of plasmid RI, induce efficient binding of
DnaA to the dnaA box. However, specific binding of
DnaA to oriR was not detected by DNase I protection
experiments in the absence of the dnaA box. These
results suggest that the entrance of the DnaA protein
in or/R is promoted initially by interactions with a RepA-
orMR pre-initiation complex and that, in the absence of
the dnaA box, these interactions can support, with
reduced efficiency, DnaA dependent replication of
plasmid RI.
INTRODUCTION
Replication of plasmid RI in E.coli extracts is dependent on,
among other proteins, the plasmid RepA and the host DnaA
proteins (1,2). The 9 bp recognition site for DnaA, or dnaA box
(3) is present in oriR, the minimal origin of replication of RI
(2). RepA protein binds to oriR sequences that span nearly 100
bp downstream from the dnaA box and promotes binding of the
DnaA protein to this box (2). It is not clear if this effect is
modulated by DnaA-RepA interactions and/or by structural
modifications of oriR induced by RepA.
The DnaA protein can act as a replisome organizer (4,5). It
has been proposed, by analogy with the situation in oriC, that
DnaA promotes assembly of a DnaB-DnaC pre-priming complex
at the 9 bp repeats present in the A+T-rich region of oriR that
share homology with the 13-mers of oriC (6). Deletion of the
A+T rich region of oriR does not prevent binding of the DnaA
and RepA proteins, but results in complete loss of RI replication
(2). The potential role of DnaA in melting oriR at the A+T rich
region is probably dispensable for RI replication: the ADP form
of DnaA, inactive in melting oriC sequences (6,7), seems to be
sufficient for Rl replication (unpublished data mentioned in 8).
In the absence of DnaA, RepA can promote replication of RI
in vivo, both in the autonomous and the integrated situations
(9,10). This implies the ability of the RepA protein to open the
helix and to promote the assembly of the replisome complex at
the origin of replication. However, replication of RI in the
absence of DnaA and in the presence of normal levels of RepA
protein is very inefficient (11) and this type of replication has
not been detected in vitro (1). These data indicate that, although
RI can replicate in DnaA-dependent and DnaA-independent
modes, under normal conditions the DnaA-dependent mode is
predominant.
In this paper we further analyze interactions between RepA,
DnaA and oriR, using wild-type and mutated RepA proteins and
oriR sequences. The repA mutant used here codes for a RepA
protein unable to support in vitro replication of RI (12) but that
still binds to oriR (Giraldo and Dfaz, submitted). This mutant
opens the possibility to investigate if the full replication capacity
of the RepA protein is required to promote binding of DnaA to
the dnaA box. The data we present are consistent with an initial
entrance of the DnaA protein in oriR promoted by a RepA-oriR
pre-initiation complex and indicate that although utilization of
DnaA is favoured by the dnaA box present in oriR, this box is
dispensable for the DnaA dependent replication of plasmid RI.
MATERIAL AND METHODS
Bacterial strains and plasmids
All bacterial strains were E.coli K12. TGl (13) and BMH71-18
(14) were used for propagation of M13-based vectors or
recombinants and in experiments using site-directed mutagenesis.
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JM83 (15) was used to rescue and identify pUC-type
recombinants. C600 was used for the preparation of in vitro
replication extracts and also as a host for mini-RI plasmids.
Bacterial plasmids used in this work are indicated in Table 1.
Basic manipulations with DNA
Techniques used for the preparation of DNA, gel electrophoresis
of DNA fragments and basic manipulations with enzymes that
act on DNA, were as described (13). Purification of DNA
fragments from agarose gels was done by elution using the
Geneclean kit (BIO 101). Transformation of E.coli with DNA
was done as described (16) with modification for M13 derivatives
described in the 'M13 cloning and sequencing manual' edited
by Amersham. DNA sequencing by the chain terminating method
(17) was done using the M13 sequencing kit from Amersham
according to the specifications of this supplier. Sequencing of
linear fragments, A+G reactions, were done as described by
Maxam and Gilbert (18). Oligonucleotide site-directed
mutagenesis using M13 vectors was done using either the
protocols described by Carter et al. (19) or the kit
'Oligonucleotide-directed in vitro mutagenesis system' (version
2) from AMERSHAM.
In vitro replication analysis
Cell-free extracts were prepared from cultures of C600. In vitro
replication of the mini-RI plasmids pRGIOA and pRGIOB were
assayed in tye I extracts, in which RepA is synthesized de novo
during the assay (20). Replicative forms of M13-oriR
recombinants were assayed in type II extracts supplemented with
partially purified RepA protein, as described by Ortega et al.
(1). Polyclonal antiserum against DnaA prepared from rabbit,
was a kind gift of M.Kohiyama. This antiserum was added to
the in vitro reaction mixtures at a dilution of 1:50 and these
samples were incubated for 20 minutes at 0°C before starting
the replication assay.
Copy number determinations
Relative copy number of the pKN177-type copA miniplasmids
pRG1OA and pRG1OB were evaluated by determining the
maximum level of resistance to ampicillin as described (21).
DNase I footprint analysis
Protocols were adapted by Giraldo and Dfaz (Submitted for
publication) from those described by Galas and Schmitz (22) and
Masai and Arai (2). 12.5 ng (53.0 fmol, 25000 cpm) of the 359
bp oriR fragments ofpRG22 and pRG220, 3'-end labelled at the
XbaI site, 135 ng of RepA or RepA2623 proteins (4 pmol; molar
ratios RepA/oriR=75.5) and 100-1000 ng of DnaA protein
(1.8-18.0 pmol; molar ratios RepA/DnaA=2.2-0.27) were
used. Incubation mixtures, 49 ,i in volume, were in 25 mM
Hepes-KOH pH= 8.0, 50 mM KCI, 10 mM Mg-acetate, 4 mM
DTT, 2 mM ATP, 4% sucrose and 50 ,g/ml bovine serum
albumine. The proteins and the oriR fragments were incubated
for 15 min. at 0°C; then 1 ,ul of calf thymus competitor DNA
(0.5 mg/ml) was added to each sample and these were further
incubated at 30°C for 15 min. Finally the samples were digested
for 1 min. at room temperature with 2.5 or 5.0 ng (samples
without or with proteins, respectively) DNase I. After the DNase
I digestion, the samples were phenol-chloroform extracted,
ethanol precipitated and loaded onto a 6% polyacrilamide-7M
urea sequencing gel, in parallel with A+G chemical sequencing
Table 1. Plasmids
dnaA boxes'
Plasmids Relevant construction 1 2 Marker Source/Reference
M13mp9 cloning vector - - ApR (25)
pS03 M13mp9xBamHI wt wt AP (1)
+oriR-Sau3A
pS033 " mut. wt ApR This work
pS0338 " mut. mut. ApR This work
pUC18 cloning vector - - ApR (15)
pRG22 pUC18 xAccI wt wt APR R.Giraldo
+oriR-Hpall
pRG220 " mut. wt ApR This work
pRG1OA2 RI-copA-miniplasrnid wt wt Ap This work
pRGlOB2 " mut. wt Ap This work
tdnaA box-1: 5'TTATCCACA3'(coordinates 1428-1436); dnaA box-i mutant:
5'TGCGATACA3'. dnaA box-2: 5'TAATACAAA3' (cdnats 1392-1400).
dnaA box-2 mutant: 5'TAATATCAA3'. (see Fig. IA). 2The structure of
pRGIOA and pRGIOB is the same of plasmid pKN177 (26,27), except for a 128
bp deletion at cordinates 1659-1787 (see Fig. IA).
The RepA protein used in the DNase I protection experiments
was obtained first in an insoluble form (1) and then solubilized
by treatnent with 3M guanidium hydrochloride, followed by
addition of the zwitterionic detergent CHAPS to 1.0% and
dialysis against 25 mM Hepes-KOH pH=8.0, 0.5 M KC1, 2 mM
DiT, 0.1 mM EDTA and 10% ethyleneglycol (Giraldo and Dfaz,
submitted). The RepA wt and RepA2623 parions used
contained respectively 1550 ug/ml and 1260 isg/ml of total protein
and were 15-20% pure. The DnaA p on (23) was a kind
gift of M.Kohiyama. This preparation contained 2300 lAg/ml of
total protein and was 40% pure.
RESULTS
Plasnid Rl replicates in vitro in a DnaA dependent mode in
the absence of the dnaA box present In oriR
The strict requirement ofDnaA for in vitro replication of plasmid
RI (1), made it interesting to test if the dnaA box present in oriR
is an absolute requirement for this replication. For tfis purpose
we isolated, by site-directed mutagenesis, a M13-oriR mutant,
pS033, in which the dnaA box at coordinates 1428-1436,
5'TTATCCACA3', was mutated in 5 positions (Fig. lA). Data
in Fig. lB indicate that replicative forms ofthis oriR mutant can
be replicated in type II extracts supplemented with partially
purified RepA protein. However, the level of replication of
pS033 was only 20% of the pS03 control, which indicates -that
although the dnaA box is not strictly required, its presence
determines an increased efficiency of replication. The occurrence,
28 bp upstream from the minimal origin, of a 9 bp sequence,
5'TAATACAAA3', differing in only one base (in bold) from
the consensus dnaA box, made it interesting to test if the
replication ofpS033 involved the utilization of this box. For this
purpose we constructed pS0338, a mutant of pSO33 mutated
in both sequences sharing homology to the consensus dnaA box
(Fig. IA), and tested replication of this mutant in vitro. It was
found that pS0338 and pS033 replicate with similar efficiencies
(Fig. iB). This result indicates that the RepA-dependent
replication of pS033 which lacks the dnaA box present in oriR
is not due to the utilization of the second and imperfect dnaA
box present 28 bp upstream from oriR.
According to these results it should be possible to isolate RI
reactions of the same fragment (18). plasmids containing the mutated dnaA box present in pSO33.
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Figure 1. A. Relevant information on the Sau3A fragment of RI that includes oMR. * dnaA boxes, RepA binding region,-o-o.''9-mers present in the A+T
rich region, origin region as defined by electron microscopy, r-+ initiation of leading strand synthesis. Enlarged: region that contains two sequences homologous
to the consensus dnaA box of E. coli. * indicates base changes in these sequences introduced by site directed mutagenesis. The relevant sequences corresponding
to the M13-oriR and mini-RI plasmids used, are indicated. Coordinates are as described by Ryder et al. (28). B. In vitro replication of M13-oriR recombinants
pSO3 (0), pSO33 (e) and pS0338 (A) in type II extracts suplemented with partially purified RepA protein. The background line (A) corresponds to samples
of pS03 treated with novobiocin (25 jig/ml). C. In vitro replication analysis of RI miniplasmids in type I extracts: (0) replication of pRGIOA, (0) replication
of pRGIOB, (A) replication of pRGIOB in the presence of polyclonal antibodies against DnaA protein. D. Ampicillin resistance levels determined by plasmids pRGIOA
(0) and pRGIOB (0).
As predicted, a copA mini-RI derivative containing the mutated
dnaA box, pRGOB, was easily isolated (Table 1). Replication
of this mutant and the parental plasmid, pRGIOA, were tested
in vitro using type I extracts. Again, the mutation in the dnaA
box reduced the level of replication to 20% of that observed with
the parental miniplasmid (Fig. IC). Replication of the mutants
lacking the dnaA box sequences should be DnaA-dependent
because in vitro replication of plasmid RI requires DnaA (1).
This prediction was evaluated directly by measuring the effect
of polyclonal antibodies against DnaA on the in vitro replication
of pRGIOB. Addition of DnaA antiserum to the replication assays
reduced replication of both pRGIOA and pRGIOB to the
background level, and the same amount of preinmune serum
inhibited less than 15% replication of these miniplasmids. From
these results it can be concluded that the dnaA box is not
absolutely required for the action of the DnaA protein in initiation
of Rl replication in vitro, although its presence improves the
efficiency of the process.
The dnaA box of oriR is required for maximal efficiency of
mini-Ri replication in vivo
The effect of the mutation in the dnaA box on the efficiency of
RI replication was also evaluated in vivo. For this purpose we
determined the relative copy number of pRGlOA and pRGlOB
comparing the maximun levels of resistance to ampicillin
conferred by these plasmids. Data shown in Fig. ID indicates
that 1.75 mg/ml and 2.5 mg/ml are the maximun ampicillin
concentrations to which 100% of the cells bearing pRG1OB and
pRG1OA, respectively, are resistant. This indicated that the
mutation in the dnaA box reduces to 70% the efficiency of
replication of RI miniplasmids in vivo. Although pKN177 can
replicate in vivo in the absence of DnaA, this replication is only
7% of the control (data not shown) which indicates that replication
of Rl in the absence of the dnaA box is mainly DnaA dependent.
It can be concluded that, both in vivo and in vitro, the dnaA box
present in oriR is dispensable for the action of the DnaA protein
in RI replication, but it is required for maximal efficiency of
replication.
Binding ofDnaA to oniR can be promoted by a RepA mutant
protein that binds to oniR but fails to support replication of
Rl, and requires the sequences of the dnaA box
The capacity of RepA, probably as part of a RepA-oriR complex,
to promote binding of DnaA to the dnaA box of the minimal
origin, lead us to question if the full replication capacity ofRepA
is required to promote this binding. To answer this question we
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Figure 2. DNase I protection of wild-type oriR sequences by RepA, RepA2623
and DnaA proteins. 53 fmol of wild-type 3'-32P-oriR 359 bp fragment labelled
in XbaI, was treated with DNase I in the presence of proteins RepA wild-type
or mutant and/or DnaA as indicated. pmol of proteins used are indicated above
the tracks. The combination of proteins are indicated. A+G: Maxam and Gilbert
reactions for these bases on the oriR fragment. The coordinates corresponding
to the dnaA box are indicated on the left side of the figure.
used a mutated RepA protein, RepA2623, that is unable to support
in vitro replication of plasmid RI (12). Recent studies indicate
that purified RepA2623 protein can bind to oriR sequences but
that this mutant is affected in cooperative interactions that led
to the formation of high order RepA-oriR complexes (Giraldo
and Dfaz, submitted). The ability ofRepA2623 protein to
binding of DnaA to wild-type oriR sequences was evaluated
comparatively with that of the RepA wild-type protein by DNase
I protection experiments as indicated in Material and Methods.
Saturating amounts of the mutant and wild-type replication
proteins (4.0 pmol) and increasing amounts of the DnaA protein
(1.8-18.0 pmol) were used. Protection of oriR from DNaseI
digestion by RepA, RepA2623 or DnaA proteins alone, was also
performed. Data in Fig. 2 indicate that i) RepA is required, as
described, for binding of DnaA to the dnaA box, ii) RepA2623
induces, with similar efficiency to wild-type RepA protein,
binding of DnaA to the dnaA box. Note that RepA2623 binds
to oriR but interacts less efficiently than the RepA protein with
Figure 3. DNase I protection by RepA and/or DnaA ofonR sequences mutated
in the dnaA box-i. 53 fmol of 3'-32P-oiR 359 bp mutated fragment labelled in
XbaI, were digested with DNase I in the presence of proeins RepA and/or DnaA
as indicated. pmol of proteins used are indicated above the tracks. A+G indicate
Maxam and Gilbert reactions. Bases altered by mutagenesis are in bold character.
The coordinates corresponding to the dnaA box are indicated on the left side of
the figure.
the region of oriR distal to the dnaA box. These results are
consistent with a role of a RepA-orR complex in promoting
binding ofDnaA to the dnaA box. In addition, they indicate that
the full replication activity of RepA is not required for this
binding.
The strict requirement of the RepA protein for the interaction
of DnaA with the dnaA box and the DnaA dependent replication
of RI observed in the dnaA box mutant, made it interesting to
test if this box is required for the interaction of the DnaA protein
with orR. For this purpose we evaluated, by DNase I protection
experiments, binding of DnaA to oriR carrying the 5 bp changes
in the dnaA box. The results obtained show that DnaA, alone
or in combination with saturating amounts of RepA, fails to
protect sequences in the mutated dnaA box (Fig. 3). This result
indicates that the footprint of DnaA in the dnaA box is the
consequence of specific interactions of DnaA with these
sequences.
RepA (pDroln
DnaA ipmnoh
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DISCUSSION
In this work we show that mutants having the dnaA box of oriR
disrupted by mutation replicate in vitro at a reduced but significant
level and that this replication, that is dependent on the RepA
protein, is specifically inhibited by DnaA antibodies. These data
indicate that the specific sequences of the dnaA box present in
onR are not required for the DnaA-dependent initiation ofplasmid
RI replication and are consistent with previous data that indicate
that in vitro replication of plasmid RI is strictly dependent on
the DnaA protein (1). The dnaA box mutant pRGlOB replicates
efficiently in vivo in a dnaA+ background. This result confirms
that the dnaA box present in oriR is not strictly required for the
action of the DnaA protein in initiation of RI replication. It is
interesting to note that the ratio of pRGIOB to pRGlOA replication
is almost 3 fold higher in vivo than in vitro. This could indicate
either an optimum level of DnaA protein in vivo and/or the
contribution of factor(s) which are not present or present in
limiting amounts in the in vitro replication assay.
Because of the dispensability of the dnaA box for the DnaA-
dependent replication of plasmid Rl and the requirement of RepA
for specific binding ofDnaA to oriR, it was of interest to analyze
interactions of the DnaA and RepA proteins with the oriR mutant
deficient in the dnaA box. It can be imagined that RepA protein
bound to oriR can exert a strong possitional effect for entry of
DnaA and that, even in the absence of the dnaA box, DnaA can
interact with oriR in the region adjacent to the RepA binding site.
The results presented here indicate that efficient and specific
interaction of the DnaA protein with oriR requires, in addition
to the RepA protein, the sequences of the dnaA box. It is proposed
that the induction of this binding by RepA protein is probably
due to an initial interaction of the DnaA protein with RepA protein
bound at the oriR region. Subsequent specific interaction of DnaA
with the sequences of the dnaA box will optimize this entry, but
in the absence of the dnaA box the initial protein-protein
interaction is probably sufficient for incorporation of DnaA to
the initiation complex.
The situation in RI has similarities and differences with the
situation in pSC101. It has been proposed, recently, that the
replication protein of pSC101, Rep, enhances, by protein-protein
interactions, binding of the DnaA protein to a dnaA box that is
an essential part of the origin of replication (24). Significant
binding of the DnaA protein to the dnaA box, and also to weak
affinity sites for DnaA that overlap with the RepA binding site,
were found in the absence of the Rep protein of pSC101. In this
plasmid, deletion of the high-affinity binding-site for DnaA leads
to inactivation of plasmid replication (26). Although in RI
destruction of the dnaA box present in onR by punctual mutations
is compatible with replication, it is not known if deletion of this
box leads to the inactivation of RI replication. This could well
be the case if this box was placed in an spacer or if the overlap
between the high-affinity binding-site for RepA and the dnaA
box (Giraldo and Diaz, submitted) were relevant for the action
of RepA in oriR. On the other hand, the possibility that point
mutations in the dnaA box of pSC101 were compatible with
replication has not been explored.
Finally, our results underline the flexibility of the mechanism
of initiation of replication catalized by RepA: this protein
promotes initiation of RI replication that is maximally efficient
in the presence of DnaA and the dnaA box but that can also occur,
with decreased efficiency, in the absence of the dnaA box and
to catalyse opening of the helix and assembly of the replisome
complex at the origin of replication in the absence of DnaA, the
dnaA box and the DnaA protein are important to optimize the
initiation frequency in order to allow the copy number control
system to couple replication of the plasmid to the growth of the
host cell efficiently.
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